Northwest Biotherapeutics (NWBO) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free NWBO Stock Alerts $0.51 +0.01 (+2.00%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Northwest Biotherapeutics Short Interest DataCurrent Short Volume45,844,600 sharesPrevious Short Volume45,479,700 sharesChange Vs. Previous Month+0.80%Dollar Volume Sold Short$23.79 millionShort Interest Ratio / Days to Cover9.3Last Record DateMarch 31, 2024Outstanding Shares1,203,330,000 sharesPercentage of Shares Shorted3.81%Today's Trading Volume1,123,818 sharesAverage Trading Volume1,740,477 sharesToday's Volume Vs. Average65% Short Selling Northwest Biotherapeutics ? Sign up to receive the latest short interest report for Northwest Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNWBO Short Interest Over TimeNWBO Days to Cover Over TimeNWBO Percentage of Float Shorted Over Time Ad Paradigm PressAI “wealth window” is closing soon!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… Northwest Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202445,844,600 shares $23.79 million +0.8%N/A9.3 $0.52 3/15/202445,479,700 shares $23.97 million +0.5%N/A17.1 $0.53 2/29/202445,237,600 shares $24.83 million +0.8%N/A13.2 $0.55 2/15/202444,861,300 shares $25.08 million -1.5%N/A12.3 $0.56 1/15/202445,906,000 shares $29.27 million -0.5%N/A14 $0.64 12/31/202346,139,800 shares $32.34 million +0.8%N/A11.1 $0.70 Get the Latest News and Ratings for NWBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/202345,776,800 shares $33.87 million -1.9%N/A19.9 $0.74 11/30/202346,647,900 shares $35.45 million -5.3%N/A15.3 $0.76 11/15/202349,260,600 shares $41.50 million -11.6%N/A10.1 $0.84 10/31/202355,750,400 shares $42.93 million +2.8%N/A18.6 $0.77 10/15/202354,229,800 shares $37.36 million +3.6%N/A12.2 $0.69 9/30/202352,330,400 shares $47.60 million +2.7%N/A5.3 $0.91 9/15/202350,976,500 shares $35.00 million +4.2%N/A12.1 $0.69 8/31/202348,940,600 shares $28.15 million +3.1%N/A8.8 $0.58 8/15/202347,481,100 shares $23.42 million +5.5%N/A15.5 $0.49 7/31/202344,998,100 shares $23.83 million +1.6%N/A16.9 $0.53 7/15/202344,299,500 shares $24.67 million +2.3%N/A18.4 $0.56 6/30/202343,316,900 shares $24.60 million +3.2%N/A17.2 $0.57 6/15/202341,973,700 shares $27.29 million +3.0%N/A10.9 $0.65 5/31/202340,738,000 shares $24.44 million +2.2%N/A18.7 $0.60 5/15/202339,849,500 shares $24.49 million +6.5%N/A12.7 $0.61 4/30/202337,419,400 shares $18.71 million -4.7%N/A8.9 $0.50 4/15/202339,268,700 shares $21.05 million +0.3%N/A12 $0.54 3/31/202339,133,700 shares $24.46 million -0.3%N/A10 $0.63 3/15/202339,268,200 shares $22.97 million -2.2%N/A15.8 $0.59 2/28/202340,154,000 shares $26.30 million +2.8%N/A14.6 $0.66 2/15/202339,064,000 shares $26.76 million +0.9%N/A9.4 $0.69 1/31/202338,719,500 shares $27.34 million -6.3%N/A12.7 $0.71 1/15/202341,300,600 shares $30.15 million -1.4%N/A9.5 $0.73 12/30/202241,886,300 shares $32.86 million +0.3%N/A11.1 $0.78 12/15/202241,783,300 shares $37.02 million +8.3%N/A6.9 $0.89 11/30/202238,579,900 shares $32.37 million +40.5%N/A2.9 $0.84 11/15/202227,453,900 shares $25.88 million +0.4%N/A5.8 $0.94 10/31/202227,335,600 shares $20.67 million -0.7%N/A11.8 $0.76 10/15/202227,532,400 shares $18.56 million -1.7%N/A13.6 $0.67 9/30/202228,010,900 shares $20.00 million -3.6%N/A12.2 $0.71 9/15/202229,057,900 shares $21.65 million -4.7%N/A9.1 $0.75 8/31/202230,503,400 shares $21.20 million -2.9%N/A7.8 $0.70 8/15/202231,424,300 shares $19.58 million -1.2%N/A12.1 $0.62 7/31/202231,803,000 shares $22.34 million +1.8%N/A11.5 $0.70AI “wealth window” is closing soon! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… NWBO Short Interest - Frequently Asked Questions What is Northwest Biotherapeutics' current short interest? Short interest is the volume of Northwest Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 45,844,600 shares of NWBO short. Learn More on Northwest Biotherapeutics' current short interest. What is a good short interest ratio for Northwest Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NWBO shares currently have a short interest ratio of 9.0. Learn More on Northwest Biotherapeutics's short interest ratio. Is Northwest Biotherapeutics' short interest increasing or decreasing? Northwest Biotherapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 45,844,600 shares, an increase of 0.8% from the previous total of 45,479,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Northwest Biotherapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Northwest Biotherapeutics: Gracell Biotechnologies Inc. (1.64%), Icosavax, Inc. (0.99%), Arcturus Therapeutics Holdings Inc. (19.60%), Harpoon Therapeutics, Inc. (4.31%), Enanta Pharmaceuticals, Inc. (13.94%), Akebia Therapeutics, Inc. (6.40%), Zevra Therapeutics, Inc. (5.63%), Vaxart, Inc. (9.89%), Theseus Pharmaceuticals, Inc. (2.63%), Sagimet Biosciences Inc. (19.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Northwest Biotherapeutics stock? Short selling NWBO is an investing strategy that aims to generate trading profit from Northwest Biotherapeutics as its price is falling. NWBO shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Northwest Biotherapeutics? A short squeeze for Northwest Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NWBO, which in turn drives the price of the stock up even further. How often is Northwest Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWBO, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GRCL Short Interest Data ICVX Short Interest Data ARCT Short Interest Data HARP Short Interest Data ENTA Short Interest Data AKBA Short Interest Data ZVRA Short Interest Data VXRT Short Interest Data THRX Short Interest Data SGMT Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWBO) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & Company